Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-06-10

FDA Approved: DIPHENHYDRAMINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)

View source ↗

Summary

FDA approved a supplemental application for diphenhydramine hydrochloride (PAI Pharma) under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diphenhydramine hydrochloride (Diphenhydramine hydrochloride)

Snippet

SUPPL AP for DIPHENHYDRAMINE HYDROCHLORIDE (DIPHENHYDRAMINE HYDROCHLORIDE)